| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Xenetic Biosciences Inc (NASDAQ: XBIO)
XBIO Technical Analysis
5
| As on 8th Oct 2025 XBIO STOCK Price closed @ 10.36 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.98 & Strong Buy for SHORT-TERM with Stoploss of 3.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XBIOSTOCK Price
| Open | 11.70 | Change | Price | % |
| High | 13.93 | 1 Day | 6.07 | 141.49 |
| Low | 9.34 | 1 Week | 7.12 | 219.75 |
| Close | 10.36 | 1 Month | 7.47 | 258.48 |
| Volume | 47316915 | 1 Year | 5.67 | 120.90 |
| 52 Week High 4.72 | 52 Week Low 2.30 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| ADAP | 0.21 | 50.00% |
| WBA | 11.98 | 0.50% |
| OPEN | 8.49 | -8.61% |
| AMD | 235.56 | 11.37% |
| PLUG | 3.65 | -5.68% |
| NVDA | 189.11 | 2.20% |
| LMDX | 0.02 | 0.00% |
| PCSA | 0.48 | 33.33% |
| BITF | 4.00 | 15.27% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XBIO Daily Charts |
XBIO Intraday Charts |
Whats New @ Bazaartrend |
XBIO Free Analysis |
|
|
XBIO Important Levels Intraday
| RESISTANCE | 19.20 |
| RESISTANCE | 16.37 |
| RESISTANCE | 14.61 |
| RESISTANCE | 12.86 |
| SUPPORT | 7.86 |
| SUPPORT | 6.11 |
| SUPPORT | 4.35 |
| SUPPORT | 1.52 |
XBIO Forecast October 2025
| 4th UP Forecast | 11.96 |
| 3rd UP Forecast | 11.45 |
| 2nd UP Forecast | 11.13 |
| 1st UP Forecast | 10.81 |
| 1st DOWN Forecast | 9.91 |
| 2nd DOWN Forecast | 9.59 |
| 3rd DOWN Forecast | 9.27 |
| 4th DOWN Forecast | 8.76 |
XBIO Weekly Forecast
| 4th UP Forecast | 11.57 |
| 3rd UP Forecast | 11.18 |
| 2nd UP Forecast | 10.94 |
| 1st UP Forecast | 10.70 |
| 1st DOWN Forecast | 10.02 |
| 2nd DOWN Forecast | 9.78 |
| 3rd DOWN Forecast | 9.54 |
| 4th DOWN Forecast | 9.15 |
XBIO Forecast2025
| 4th UP Forecast | 32.96 |
| 3rd UP Forecast | 25.71 |
| 2nd UP Forecast | 21.23 |
| 1st UP Forecast | 16.75 |
| 1st DOWN Forecast | 3.97 |
| 2nd DOWN Forecast | -0.51 |
| 3rd DOWN Forecast | -4.99 |
| 4th DOWN Forecast | -12.24 |
Xenetic Biosciences Inc ( NASDAQ USA Symbol : XBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XBIO Business Profile
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. The company is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Address: 40 Speen Street, Framingham, MA, United States, 01701
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service